EGFR and chordoma: We undertook a combination screen in the UM-Chor1 clival chordoma cell line and tested a panel of 133 US Food and Drug Administration (FDA)-approved anticancer drugs in combination with two EGFR/ErbB inhibitors (afatinib and erlotinib).